Improving NHS Outcomes Through Research, Funding and Innovation
further & higher education
health & social care
This Forum will provide delegates with the opportunity to survey the current policy landscape and funding opportunities for research and innovation in healthcare whilst also hearing about the transformative impact that outstanding research and innovation has had on the health sector. Attendees will explore insights from NHS Trusts, think tanks, medical research institutes and HE institutions on how to produce outstanding, innovative research that has a wide-ranging impact on health outcomes across the NHS. Moreover, best practice case studies will examine how cross-sector collaboration, patient involvement in research, emerging technologies and data can enhance healthcare practices and improve outcomes.
This even is specifically designed for the Higher Education and Healthcare sectors. Typical job titles will include:
- Heads of Research Development
- Medical Directors
- Medical Researchers
- Science Advisers
- Senior Health Researchers
- Deputy and Pro-Vice Chancellors
- NHS Directors of Research and Development
- Senior Professors
- Deans of Research and Enterprise
- Innovation Managers
- Heads of Engagement
This event will also be open to the Voluntary and Private sectors to encourage networking, discussion and debate.
Key Speakers Confirmed:
- Chris Green MP, Chair, All-Party Parliamentary Group on Medical Research
- Dr Kath Mackay, Interim Director – Ageing Society, Health & Nutrition, Innovate UK
- Dr Robin Buckle, Chief Science Officer, Medical Research Council
- Dr Gary Hickey, Senior Public Involvement Manager, INVOLVE
- Dr Usha Boolaky, Assistant Director of Research, Health Foundation
- Professor Sir Robert Lechler, Executive Director, King’s Health Partners
View the agenda and additional speakers
Registration, Refreshments and Networking
Chair's Welcome Address
Dr Sonja Marjanovic, Senior Research Leader, RAND Europe and The Healthcare Improvement Studies Institute (CONFIRMED)
Morning Keynote: Ensuring the Success of the UK's Medical Research Sector Post-Brexit
- Outlining the APPG’s role in providing a forum for parliamentarians with an interest in medical research to communicate, collaborate and network with medical research professionals
- Evaluating the impact of Brexit on medical research capacity, and exploring opportunities to enhance the UK’s world-leading research status
- Ensuring the continuation of international collaboration and mobility between medical researchers and health experts in the UK and wider global community post-Brexit
- Understanding the crucial role played by patient data in medical research by enabling practitioners to deliver more effective treatments, interventions and diagnoses
- Analysing medical research funding implications in a post-Brexit environment
Chris Green MP, Chair, All-Party Parliamentary Group on Medical Research (CONFIRMED)
Special Keynote: Supporting Innovative Research to Enhance Outcomes Across the NHS
- Outlining the competitive funding opportunities available as part of the £300 million landmark ageing society Grand Challenge
- Delivering the leading-edge healthcare challenge as part of the Industrial Strategy Challenge Fund, investing £181 million to accelerate access to new medicines and drugs and improve healthcare
- Awarding £21 million to companies, universities and NHS hospitals to establish advanced therapy treatment centres designed to develop new medicines for treating blood cancer
- Funding multidisciplinary teams of clinicians, academics, product-developers and logistics companies to create bespoke systems capable of operating across the entire NHS
- Emphasising the importance of supporting innovation in health and nutrition, alongside clinical and biomedical research, to improve public health outcomes
Dr Kath Mackay, Interim Director – Ageing Society, Health & Nutrition, Innovate UK (CONFIRMED)
Questions and Answers Session
Refreshments and Networking
Case Study: Developing Effective Clinical-Academic Partnerships to Enhance Patient Care Through Innovation, Research and Education
- Bringing together NHS Trusts and Kings College London to marry world-class research, education and clinical practice for the benefit of patients
- Translating the benefits of cutting-edge medical research into better patient care as quickly and effectively as possible through the organisation’s numerous Clinicial Academic Groups (CAGs)
- Developing the current and future NHS workforce by providing innovative training courses and learning resources, quality assured by experts from across the NHS and Higher Education sector
- Showcasing how partnership working has allowed advances in biomedical research to demonstrably improve clinical outcomes for patients, such as using wearable technology to halt diabetes
Professor Sir Robert Lechler, Executive Director, King’s Health Partners (CONFIRMED)
Case Study: Supporting Medical Innovation in the NHS to Effectively Meet Clinical Needs
- Working with innovators from across the health and care sector to support technology transfer into 25 NHS Trusts, ensuring patient needs are more effectively met
- Highlighting innovation success stories such as Earfold, TracheSeal and SAFIRA, and outlining how in each case HEE has assisted in proof of concept, undertaken market research, and securing patents and design rights
- Detailing HEE’s role in the Medtech Accelerator Joint Venture, bringing together NHS Trusts, medical innovators, and local and regional authorities to facilitate early stage development of medical technology
- Exploring the potential of multi-agency partnership working to ensure innovation is effectively developed and deployed to meet unmet clinical needs within the NHS
Dr Anne Blackwood, Chief Executive, Health Enterprise East (CONFIRMED)
Questions and Answers Session
Lunch and Networking
Afternoon Keynote: Funding the Vanguard of Medical Researchers to Enhance Healthcare Outcomes
- Shaping the UK biomedical research landscape through strategic funding of cutting-edge research projects across a variety of fields, including infections and immunity, cellular and systems medicine, population science, neurosciences and mental health
- Detailing how £800m in annual funding is allocated; outlining MRC strategic priorities and funding opportunities
- Establishing major new national research institutes in health data science and dementia, the latter in partnership with Alzheimer’s Society and Alzheimer’s Research UK in accordance with the Prime Minister’s 2020 Challenge on Dementia
- Demonstrating high-impact health outcomes through MRC-funded research, such as developing new therapies and diagnostics, and delivering innovative adaptive clinical trials to transform the efficiency of drug development and expedite patient access to effective treatments
- Supporting the careers and development of creative and innovative clinical scientists
Dr Robin Buckle, Chief Science Officer, Medical Research Council (CONFIRMED)
Case Study: Translating Health Research into Practical Resources for NHS Practitioners
- Delivering multi-disciplinary medical research within the NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, in collaboration with Public Health England
- Undertaking research across 12 public health priority areas to inform public health policy; developing tools, guidelines and resources for use by healthcare practitioners
- Showcasing the Imperial Antibiotic Prescribing Policy (IAPP) mobile application, which provides clinical decision support at the point of care to improve antimicrobial stewardship
- Outlining the research value of partnering with the Wellcome Trust Sanger Institute, the Cambridge Veterinary School and the North West London Academic Health Science Network
Dr Ahmad was awarded the prestigious NIHR Fellowship in Knowledge Mobilisation in 2016
Dr Raheelah Ahmad, Research Fellow, and Healthcare Management Lead – Health Protection Research Unit, Imperial College London (CONFIRMED)
Questions and Answers Session
Refreshments and Networking
Special Keynote: Public and Patient Involvement in Health Research - What, Why and How?
- Outlining the various benefits of patient and public involvement in clinical research, including the value of alternative perspectives, improvements in research quality and relevance, the moral imperative to involve patients and public, and increased funding eligibility
- Exploring the added value of patient involvement in health research
- Providing guidance on how to ensure the correct research architecture is in place for effective and authentic public involvement, such as appropriate budgeting, time considerations, and research skills training
- Sharing details around an NIHR-wide project examining how co-production could be used to improve public involvement in research
Dr Gary Hickey, Senior Public Involvement Manager, INVOLVE (CONFIRMED)
Case Study: Successfully Delivering ‘Joined-Up’ Healthcare Through Collaborative Digital Innovation
- Detailing how the North West London Collaboration of Clinical Commissioning Groups (CCGs) has delivered effective ‘joined-up’ care through its innovative Whole Systems Integrated Care (WSIC) programme
- Tracking the process of bringing together over 30 organisations, community groups and lay partners, including service users and carers, to develop a shared vision of the WSIC programme
- Generating an integrated care record via the WSIC dashboard by linking data from across four acute, two mental health and two community NHS Trusts, eight local boroughs and 380 GP practices
- Outlining the benefits of utilising a WSIC platform for patients and clinicians, such as being able to more easily identify gaps in a patient’s care pathway and aiding the monitoring of patient outcomes
- Highlighting how embedding the WSIC dashboard into local care processes can support the delivery of NHS Sustainability and Transformation Plans (STPs) to make them more efficient and effective
- Exploring key challenges to adoption and implementation, including information governance, a fast-evolving organisational landscape, and effective cross-sector stakeholder engagement
Dr Ian Goodman, Chair, Hillingdon CCG (CONFIRMED)
Closing Keynote: Making Health Policy and Practice More Effective Through Evidence-Based Research
- Outlining the Health Foundation strategy 2019 and beyond, including understanding how its work influences policy and practice and the challenges associated with this
- Remodelling innovation and improvement programmes and research to support better outcomes
- Highlighting the importance of working across disciplinary boundaries in health and social care, and how the Foundation is seeking to address this through its work, including engaging front line staff and people with lived experience in the design of research programmes
- Exploring Foundation’s focus on the social and wider determinants of health, beyond the NHS, promoting health as an asset for all
Dr Usha Boolaky, Assistant Director of Research, Health Foundation (CONFIRMED)
Questions and Answers Session
Chair's Summary and Close
*Programme subject to change
The NHS is facing innumerable challenges in delivering efficient, high-quality and patient-centred healthcare. In 2017, 2.3 million patients waited over four hours to be seen in A&E in England in 2017, while 29 trusts and NHS boards have missed all of their A&E, cancer and routine operations targets in 2018. This is in part due to increased demand for NHS services, with the numbers visiting A&E having risen by over 40% in 13 years. The UK’s growing and ageing population is placing ever greater strain on healthcare providers, with current trends suggesting that by 2044 nearly a quarter of the UK population will be over 65. Moreover, the country is struggling with obesity; indeed, 1/3 of adults face severe health risks as a result of their weight. This, combined with the increase of other long-term chronic conditions such as dementia, places the NHS in an extremely onerous position.
Research and innovation (R&I) in healthcare will be at the forefront of combating these issues and assisting the NHS in dealing with the various pressures it faces. The government’s commitment to spend 2.4% of GDP on research and development by 2027 offers a prime opportunity to advance health outcomes across the health sector through targeted R&I. In July 2018, Jeremy Hunt announced £215 million in funding for research into emerging health issues and the pressures facing the NHS. Furthermore, the Government’s NHS Long Term Plan released in January 2019 states the ambition to treble industry contract and R&D collaborative research in the NHS over ten years to nearly £1 billion, as well as as working to increase the number of people participating in health research to one million by 2023/24.
The NHS Long Term Plan also endorses the 2018 Life Sciences sector deal and encourages greater integration between the life science R&I community and the NHS, to ensure scientific advances in healthcare result in better treatments and diagnoses for patients. Moreover, Innovate UK announced up to £6 million will be available in grant funding for precision medicine projects that improve the diagnosis, monitoring and treatment of disease. A Biomedical Catalyst fund of £10 million has also been formed between Innovate UK and the Medical Research Council to support innovation in the life sciences sector, while Health Data Research UK was formed in 2017 to address challenging healthcare issues through utilising data science.
For health R&I to be truly effective in meeting the medical and operational needs of the NHS, institutions from government, healthcare, the voluntary sector, higher education and industry must collaborate and collectively advance knowledge around medicine, nutrition, healthy living, and organisational effectiveness.
Dr Kath Mackay, Interim Director – Ageing Society, Health & Nutrition, Innovate UK
Kath Mackay is interim Director of Ageing Society, Health & Nutrition at Innovate UK. Kath leads a team working to grow and scale the best UK businesses developing biomedical, health, agriculture and food innovations.
Kath joined Innovate UK in 2013 to co-manage the Regenerative Medicine & Advanced Therapies Programme, working to support the growing UK cell and gene therapy industry and growing market confidence to make the sector more investable. In doing this Kath worked closely with the Cell and Gene Therapy Catapult, and latterly she has led establishment of the Medicines Discovery Catapult for Innovate UK.
She has also held the roles of Head of Precision and Discovery Medicine and Deputy Director of Ageing Society, Health & Nutrition.
Kath has a PhD in pharmacology where she researched using stem cell models for novel drug discovery applications. Prior to joining Innovate UK she held commercial biotech roles providing experience of the life sciences industry in the UK and the USA.
Dr Usha Boolaky, Assistant Director of Research, Health Foundation
Dr Usha Boolaky, Assistant Director for Research at the Health Foundation, leads the development and delivery of its major externally funded research programmes and evaluations for supporting the improvement of health care, promoting healthy lives for all, the sustainability of health and care services, and understanding the quality of care. Her work ranges from designing evaluations to support innovation and improvement in health care, through to developing strategic partnerships across academia, policy and funders.
Prior to joining the Health Foundation, Usha was at the Institute of Public Care where she led a range of programmes evaluating and supporting the implementation of policy into practice on behalf of the Department of Health, Department of Education, and the Welsh Government, as well as leading on a range of improvement programmes aimed at integrating health and social care services.
Dr Gary Hickey, Senior Public Involvement Manager, INVOLVE
Gary is a Senior Public Involvement Manager at INVOLVE responsible for our work on co-production in research and an international patient and public involvement network. He recently led a team of people to develop INVOLVE’s ‘Guidance on co-producing a research project’.
He has over a decade of experience working in health and social care research, including public and patient involvement, within a university setting, and over a decade’s experience of working in research and project management within public sector organisations, both in the UK and overseas, on ethics and corruption.
Professor Sir Robert Lechler, Executive Director, King’s Health Partners
Robert Lechler is currently Senior Vice-President (Health) at King’s College London, Executive Director of King’s Health Partners and President of the Academy of Medical Sciences. He is a strong advocate of the Academic Health Science Centre model of university-healthcare partnerships.
His clinical and research career have been focused on the pursuit of clinical transplantation tolerance. He worked in in vitro and in vivo rodent models and recently has helped to define biomarkers of clinical tolerance which has led to first in man trials of cell therapy to promote immune tolerance in recipients of kidney and liver organ transplants. He has published over 200 papers in this field. In addition, Robert is a Founding Board Member of MedCity, a Board Member of the Crick Institute and the HCA Advisory Board and a member of the Prime Minister’s Council for Science and Technology.